Alumni Ventures
AI is particularly well-suited to accelerate oncology drug development by improving target selection, patient matching, trial design, and regulatory processes—with a framework spanning four decisions (choose better, build better, test smarter, learn faster) that buyers are already paying premiums to acquire.
Topics: Biotech & Life Sciences · AI (Horizontal)
SandHill indexes 800+ venture capital blogs and newsletters and sends the best of them every Sunday. Browse the sources · browse by topic · read the blog.
Suggest a blog or newsletter for the SandHill index. We track the RSS feed and feature the best pieces in the weekly digest.
The latest theses & analyses from 800+ venture investors, curated into one email. Join 5,000+ investors, founders and LPs.